FAM8A1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.325000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.712400E-01
Normal-vs-Stage2
7.854200E-01
Normal-vs-Stage3
2.615000E-01
Normal-vs-Stage4
2.018200E-01
Stage1-vs-Stage2
3.165800E-01
Stage1-vs-Stage3
1.676420E-01
Stage1-vs-Stage4
9.937600E-01
Stage2-vs-Stage3
4.061600E-02
Stage2-vs-Stage4
9.798100E-02
Stage3-vs-Stage4
1.676750E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.274800E-01
Normal-vs-AfricanAmerican
6.638200E-01
Normal-vs-Asian
6.615400E-01
Caucasian-vs-AfricanAmerican
4.847200E-01
Caucasian-vs-Asian
5.606000E-01
AfricanAmerican-vs-Asian
2.594600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.153400E-01
Normal-vs-Female
9.316800E-01
Male-vs-Female
2.289800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.762600E-01
Normal-vs-Age(41-60Yrs)
8.628600E-01
Normal-vs-Age(61-80Yrs)
8.702600E-01
Normal-vs-Age(81-100Yrs)
8.354200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.219000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.131800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.224600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.479800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.042200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.377200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.753200E-01
Normal-vs-Daily Drinker
1.196610E-01
Normal-vs-Weekly Drinker
9.165400E-01
Normal-vs-Occasional Drinker
9.162000E-01
Normal-vs-Social Drinker
7.084200E-01
Non Drinker-vs-Daily Drinker
8.949900E-02
Non Drinker-vs-Weekly Drinker
3.455800E-01
Non Drinker-vs-Occasional Drinker
2.993600E-01
Non Drinker-vs-Social Drinker
1.097030E-01
Daily Drinker-vs-Weekly Drinker
3.652500E-02
Daily Drinker-vs-Occasional Drinker
6.922200E-02
Daily Drinker-vs-Social Drinker
1.924240E-02
Weekly Drinker-vs-Occasional Drinker
7.326000E-01
Weekly Drinker-vs-Social Drinker
4.004600E-01
Occasional Drinker-vs-Social Drinker
6.820200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.918400E-02
Normal-vs-Grade 2
3.562000E-02
Normal-vs-Grade 3
2.119800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.425400E-01
Grade 1-vs-Grade 3
1.195600E-01
Grade 1-vs-Grade 4
8.918400E-02
Grade 2-vs-Grade 3
2.832000E-01
Grade 2-vs-Grade 4
3.562000E-02
Grade 3-vs-Grade 4
2.119800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.615600E-01
Normal-vs-NonDiabetic
7.720000E-01
Diabetic-vs-NonDiabetic
8.750600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.261800E-01
Normal-vs-NoPancreatitis
8.395200E-01
Pancreatitis-vs-NoPancreatitis
4.951600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.719800E-01
Normal-vs-N1
8.145200E-01
N0-vs-N1
2.317400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.429600E-01
Normal-vs-TP53-NonMutant
5.200200E-01
TP53-Mutant-vs-TP53-NonMutant
5.71469999999241E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
